Temozolomide Capsules, 250 mg, 5-count bottle, Rx only, Manufactured by: Deva Holding A.S., 1 Merkez Mahallesi, Istanbul, Turkey 34303, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054, NDC 67877-542-07.

Class I - Dangerous

What Should You Do?

  1. Check if you have this product:
    Lot #: A062228, A062227, A062226, A062295, A062294, Exp 08/31/2019; A069325, A069323, Exp 05/31/2020; A072015, Exp 10/31/2020; A076611, A076609, A076608, A076607, Exp 04/30/2021
  2. Do not eat it: Even if it looks and smells fine, do not consume this product.
  3. Throw it away or return it: You can return the product to the store for a full refund.
  4. Seek medical attention if needed: If you've consumed this product and feel unwell, contact your doctor immediately.
  5. Report problems: Report any issues to the FDA's Safety Reporting Portal.

⚠️ Emergency: If you experience severe symptoms after consuming this product, call 911 or Poison Control at 1-800-222-1222.

Recall Details

Company:
Deva Holding AS - Cerkezkoy Subesi
Reason for Recall:
CGMP Deviations: product was manufactured that did not prevent possible cross contamination with beta lactam products.
Classification:
Class I - Dangerous

Dangerous or defective products that predictably could cause serious health problems or death.

Status:
terminated

Product Information

Full Description:

Temozolomide Capsules, 250 mg, 5-count bottle, Rx only, Manufactured by: Deva Holding A.S., 1 Merkez Mahallesi, Istanbul, Turkey 34303, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054, NDC 67877-542-07.

Product Codes/Lot Numbers:

Lot #: A062228, A062227, A062226, A062295, A062294, Exp 08/31/2019; A069325, A069323, Exp 05/31/2020; A072015, Exp 10/31/2020; A076611, A076609, A076608, A076607, Exp 04/30/2021

Official Source

Always verify recall information with the official FDA source:

View on FDA.gov

FDA Recall Number: D-1513-2019

Related Recalls

CGMP Deviations: product was manufactured that did not prevent possible cross contamination with beta lactam products.

Jul 16, 2019 Prescription Drugs Nationwide View Details →

CGMP Deviations: product was manufactured that did not prevent possible cross contamination with beta lactam products.

Jul 16, 2019 Prescription Drugs Nationwide View Details →

CGMP Deviations: product was manufactured that did not prevent possible cross contamination with beta lactam products.

Jul 16, 2019 Prescription Drugs Nationwide View Details →